Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Naples, Campania, Italy, 80131 and removed Napoli, Campania, Italy, 80131 in the Locations list to standardize the site name to English.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated to v3.5.0; v3.4.3 removed.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 has been added to the site. The previously displayed funding-status notice and Revision: v3.4.1 have been removed.SummaryDifference0.3%

- Check63 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operations was added, including a directive to check cc.nih.gov and opm.gov for updates. The revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check70 days agoChange DetectedShow glossary option has been added and the page revision updated to v3.4.0, with minor capitalization changes to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.